Post-translational modifications of Kaposi's sarcoma-associated herpesvirus regulatory proteins - SUMO and KSHV

Frontiers in Microbiology

Volumn 3, Issue FEB, 2012, Pages

  Campbell, Mel ^a   Izumiya, Yoshihiro ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

K bZIP; K Rta; KSHV; LANA; Post translational modification; SUMO; Transcription

Indexed keywords

EID: 84875595488     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00031     Document Type: Article

References (107)

1. Adamson, A. L., and Kenney, S. (2001). Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J. Virol. 75, 2388-2399.
2. An, F. Q., Compitello, N., Horwitz, E., Sramkoski, M., Knudsen, E. S., and Renne, R. (2005). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest. J. Biol. Chem. 280, 3862-3874.
3. Bachmann, M., and Moroy, T. (2005). The serine/threonine kinase Pim-1. Int. J. Biochem. Cell Biol. 37, 726-730.
4. Bajaj, B. G., Verma, S. C., Lan, K., Cotter, M. A., Woodman, Z. L., and Robertson, E. S. (2006). KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity. Virology 351,18-28.
5. Barbera, A. J., Chodaparambil, J. V., Kelley-Clarke, B., Joukov, V., Walter, J. C., Luger, K., and Kaye, K. M. (2006). The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311,856-861.
6. Bernardi, R., and Pandolfi, P. P. (2007). Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol Cell Biol. 8, 1006-1016.
7. Berube, N. G., Healy, J., Medina, C. F., Wu, S., Hodgson, T., Jagla, M., and Picketts, D. J. (2008). Patient mutations alter ATRX targeting to PML nuclear bodies. Eur. J. Hum. Genet. 16,192-201.
8. Boggio, R., Passafaro, A., and Chiocca, S. (2007). Targeting SUMO E1 to ubiquitin ligases: a viral strategy to counteract sumoylation. J. Biol. Chem. 282,15376-15382.
9. Borden, K. L. (2008). Pondering the puzzle of PML (promye locytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon? Biochim. Biophys. Acta 1783, 2145-2154.
10. Bossis, G., Malnou, C. E., Farras, R., Andermarcher, E., Hipskind, R., Rodriguez, M., Schmidt, D., Muller, S., Jariel-Encontre, I., and Piechaczyk, M. (2005). Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol. Cell. Biol. 25, 6964-6979.
11. Boutell, C., Cuchet-Lourenco, D., Vanni, E., Orr, A., Glass, M., McFarlane, S., and Everett, R. D. (2011). A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathog. 7, e1002245. doi:10.1371/journal.ppat.1002245
12. Campbell, M., Chang, P.-C., Huerta, S., Izumiya, C., Davis, R., Tepper, C. G., Kim, K. Y., Shevchenko, B., Wang, D.-H., Jung, J. U., Luciw, P. A., Kung, H.-J., and Izumiya, Y. (2011). Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen. J. Biol Chem. doi: 10.1074/jbcM111. 289496
13. Cha, S., Lim, C., Lee, J. Y., Song, Y.-J., Park, J., Choe, J., and Seo, T. (2010). DNA-PK/Ku complex binds to latency-associated nuclear antigen and negatively regulates Kaposi's sarcoma-associated herpesvirus latent replication. Biochem. Biophys. Res. Commun. 394, 934-939.
14. Chang, P. C., Fitzgerald, L. D., van Geelan, A., Izumiya, Y., Ellison, T. J., Wang, D.-H., Ann, D. K., Luciw, P. A., and Kung, H. J. (2009). Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase. Cancer Res. 69, 5681-5689.
15. Chang, P. C., Izumiya, Y., Wu, C. Y., Fitzgerald, L. D., Campbell, M., Ellison, T. J., Lam, K. S., Luciw, P. A., and Kung, H. J. (2010). Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific. J. Biol Chem. 285, 5266-5273.
16. Chang, P. J., Shedd, D., Gradoville, L., Cho, M. S., Chen, L. W., Chang, J., and Miller, G. (2002). Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements. J. Virol. 76,3168-3178.
17. Cheng, F., Weidner-Glunde, M., Varjosalo, M., Rainio, E. M., Lehtonen, A., Schulz, T. F., Koskinen, P. J., Taipale, J., and Ojala, P. M. (2009). KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA. PLoS Pathog. 5, e1000324. doi:10.1371/journal.ppat.1000324
18. Colombo, R., Boggio, R., Seiser, C., Draetta, G. F., and Chiocca, S. (2002). The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1. EMBO Rep. 3, 1062-1068.
19. Cuypers, H. T., Selten, G., Quint, W., Zijlstra, M., Maandag, E. R., Boelens, W., van Wezenbeek, P., Melief, C., and Berns, A. (1984). Murine leukemia virus-induced T-cell lymphogenesis: integration of proviruses in a distinct chromosomal region. Cell 37, 141-150.
20. Daniel, A. R., Faivre, E. J., and Lange, C. A. (2007). Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells. Mol. Endocrinol. 21, 2890-2906.
21. Daniel, A. R., and Lange, C. A. (2009). Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells. Proc. Natl Acad. Sci. U.S.A. 106, 14287-14292.
22. Deng, H., Song, M. J., Chu, J. T., and Sun, R. (2002). Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J. Virol. 76, 8252-8264.
23. Deng, Z., Atanasiu, C., Zhao, K., Marmorstein, R., Sbodio, J. I., Chi, N. W., and Lieberman, P. M. (2005). Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1. J. Virol. 79, 4640-4650.
24. Drane, P., Ouararhni, K., Depaux, A., Shuaib, M., and Hamiche, A. (2010). The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev. 24, 1253-1265.
25. Ellison, T. J., Izumiya, Y., Izumiya, C., Luciw, P. A., and Kung, H. J. (2009). A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus. Virology 387, 76-88.
26. Everett, R. D., Parada, C., Gripon, P., Sirma, H., and Orr, A. (2008). replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and sp100. J. Virol. 82, 2661-2672.
27. Everett, R. D., Rechter, S., Papior, P., Tavalai, N., Stamminger, T., and Orr, A. (2006). PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 80,7995-8005.
28. Forde, J. E., and Dale, T. C. (2007). Glycogen synthase kinase 3: a key regulator of cellular fate. Cell. Mol. LifeSci. 64, 1930-1944.
29. Friborg, J., Kong, W., Hottiger, M. O., and Nabel, G. J. (1999). p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889-894.
30. Fu, C., Ahmed, K., Ding, H., Ding, X., Lan, J., Yang, Z., Miao, Y., Zhu, Y., Shi, Y., Zhu, J., Huang, H., and Yao, X. (2005). Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 24, 5401-5413.
31. Fujimuro, M., and Hayward, S. D. (2003). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3 beta. J. Virol. 77, 8019-8030.
32. Fujimuro, M., Liu, J., Zhu, J., Yokosawa, H., and Hayward, S. D. (2005). Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. J. Virol. 79,10429-10441.
33. Ganem, D. (2010). KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J. Clin. Invest. 120, 939-949.
34. Geiss-Friedlander, R., and Melchior, F. (2007). Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947-956.
35. Girdwood, D., Bumpass, D., Vaughan, 0. A., Thain, A., Anderson, L. A., Snowden, A. W., Garcia-Wilson, E., Perkins, N. D., and Hay, R. T. (2003). P300 transcriptional repression is mediated by SUMO modification. Mol. Cell 11, 1043-1054.
36. Goldberg, A. D., Banaszynski, L. A., Noh, K. M., Lewis, P. W., Elsaesser, S. J., Stadler, S., Dewell, S., Law, M., Guo, X., Li, X., Wen, D., Chapgier, A., DeKelver, R. C., Miller, J. C., Lee, Y. L., Boydston, E. A., Holmes, M. C., Gregory, P. D., Greally, J. M., Rafii, S., Yang, C., Scambler, P. J., Garrick, D., Gibbons, R. J., Higgs, D. R., Cristea, 1. M., Urnov, F. D., Zheng, D., and Allis, C. D. (2010). Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140,678-691.
37. Goodarzi, A. A., Kurka, T., and Jeggo, P. A. (2011). KAP-1 phosphorylation regulates CHD3 nucleosome remodeling during DNA double-strand break response. Nat. Struct. Mol. Biol. 18,831-839.
38. Gwack, Y., Nakamura, H., Lee, S. W., Souvis, J., Yustein, J. T., Gyri, S., Kung, H. J., and Jung, J. U. (2003). Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication. Mol. Cell. Biol. 23, 8282-8294.
39. Hagen, T. (2009). Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3 beta. J. Virol. 83, 6312-6317.
40. Heaphy, C. M., de Wilde, R. F., Jiao, Y., Klein, A. P., Edil, B. H., Shi, C., Bettegowda, C., Rodriguez, F. J., Eberhart, C. G., Hebbar, S., Offerhaus, G. J., McLendon, R., Rasheed, B. A., He, Y., Yan, H., Bigner, D. D., Oba-Shinjo, S. M., Marie, S. K., Riggins, G. J., Kinzler, K. W., Vogelstein, B., Hruban, R. H., Maitra, A., Papadopoulos, N., and Meeker, A. K. (2011). Altered telomeres in tumors with ATRX and DAXX mutations. Science 333, 425.
41. Hofmann, H., Floss, S., and Stamminger, T. (2000). Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J. Virol. 74, 2510-2524.
42. Hsu, C. H., Chang, M. D., Tai, K. Y., Yang, Y T., Wang, P. S., Chen, C. J., Wang, Y H., Lee, S. C., Wu, C. W., and Juan, L. J. (2004). HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. EMBO J.23,2269-2280.
43. Hu, J., Garber, A. C., and Renne, R. (2002). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.J. Virol. 76, 11677-11687.
44. Hwang, S., Gwack, Y., Byun, H., Lim, C., and Choe, J. (2001). The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREB-binding protein (CBP) and represses CBP-mediated transcription. J. Virol. 75, 9509-9516.
45. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T., Strauss, J. F., 3rd, and Maul, G. G. (1999). PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147,221-234.
46. Izumiya, Y., Ellison, T. J., Yeh, E. T., Jung, J. U., Luciw, P. A., and Kung, H. J. (2005). Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification.J. Virol. 79, 9912-9925.
47. Izumiya, Y., Izumiya, C., Van Geelen, A., Wang, D. H., Lam, K. S., Luciw, P. A., and Kung, H. J. (2007). Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP. J. Virol. 81,1072-1082.
48. Kedes, D. H., Lagunoff, M., Renne, R., and Ganem, D. (1997). Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J. Clin. Invest. 100, 2606-2610.
49. Kelley-Clarke, B., De Leon-Vazquez, E., Slain, K., Barbera, A. J., and Kaye, K. M. (2009). Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence. J. Virol. 83,4326-4337.
50. Kodadek, T., Sikder, D., and Nalley, K. (2006). Keeping transcriptional activators under control. Cell 127, 261-264.
51. Komatsu, T., Ballestas, M. E., Barbera, A. J., Kelley-Clarke, B., and Kaye, K. M. (2004). KSHV LANA1 binds DNA as an oligmer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence. Virology 319, 225-336.
52. Krishnakumar, R., and Kraus, W L. (2010). The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol. Cell 39, 8-24.
53. Lan, K., Kuppers, D. A., and Robertson, E. S. (2005). Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein J-kappa, the major downstream effector of the Notch signaling pathway. J. Virol. 79, 3468-3478.
54. Ledl, A., Schmidt, D., and Muller, S. (2005). Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Oncogene 24, 3810-3818.
55. Lefort, S., Gravel, A., and Flamand, L. (2010). Repression of interferon-alpha stimulated genes expression by Kaposi's sarcoma-assocaited herpesvirus K-bZIP protein. Virology 408, 14-30.
56. Lewis, P. W., Elsaesser, S. J., Noh, K. M., Stadler, S. C., and Allis, C. D. (2010). Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc. Natl. Acad. Sci. U.S.A. 107, 14075-14080.
57. Lilley, C. E., Schwartz, R. A., and Weitzman, M. D. (2007). Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol. 15, 119-126.
58. Lim, C., Gwack, Y., Hwang, S., Kim, S., and Choe, J. (2001). The transcriptional activity of cAMP rsponse element-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Biol. Chem. 276,31016-31022.
59. Lin, D. Y., Huang, Y S., Jeng, J. C., Kuo, H. Y., Chang, C. C., Chao, T. T., Ho, C. C., Chen, Y C, Lin, T. P., Fang, H. I., Hung, C. C., Suen, C. S., Hwang, M. J., Chang, K. S., Maul, G. G., and Shih, H. M. (2006). Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24, 341-354.
60. Lin, S. F., Robinson, D. R., Miller, G., and Kung, H. J. (1999). Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus.J. Virol. 73, 1909-1917.
61. Liu, J., Martin, H., Shamay, M., Woodard, C., Tang, Q.-Q., and Hayward, S. D. (2007). Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation. J. Virol. 81, 4722-4731.
62. Lu, F., Day, L., Gao, S. J., and Lieberman, P. M. (2006). Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. J. Virol. 80,5273-5282.
63. Lukac, D. M., Kirshner, J. R., and Ganem, D. (1999). Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73, 9348-9361.
64. Lukac, D. M., Renne, R., Kirshner, J. R., and Ganem, D. (1998). Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252, 304-312.
65. Lukashchuk, V., McFarlane, S., Everett, R. D., and Preston, C. M. (2006). Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J. Virol. 82, 12543-12554.
66. Marcos-Villar, L., Lopitz-Otsoa, E, Gallego, P., Munoz-Fontela, C., Gonzalez-Santamaria, J., Campagna, M., Shou-Jiang, G., Rodriguez, M. S., and Rivas, C. (2009). Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene. J. Virol. 83, 8849-8858.
67. Mesri, E. A., Cesarman, E., and Boshoff, C. (2010). Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer 10, 707-719.
68. Murakami, Y., Yamagoe, S., Noguchi, K., Takebe, Y., Takahashi, N., Uehara, Y., and Fukazawa, H. (2006). Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus through interaction with Daxx. J. Biol Chem. 281, 28113-28121.
69. Muratani, M., and Tansey, W. P. (2003). How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol Cell Biol. 4, 192-201.
70. Nagai, S., Davoodi, N., and Gasser, S. M. (2011). Nuclear organization in genome stability: SUMO connections. CellRes. 21, 474-485.
71. Nakamura, H., Lu, M., Gwack, Y., Souvlis, J., Zeichner, S. L., and Jung, J. U. (2003). Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rtatransactivator. J. Virol. 77,4205-4220.
72. Nathan, D., Ingvarsdottir, K., Sterner, D. E., Bylebyl, G. R., Dokmanovic, M., Dorsey, J. A., Whelan, K. A., Krsmanovic, M., Lane, W. S., Meluh, P. B., Johnson, E. S., and Berger, S. L. (2006). Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev. 20, 966-976.
73. Ohsaki, E., Ueda, K., Sakakibara, S., Do, E., Yada, K., and Yamanishi, K. (2004). Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency. J. Virol. 78, 9936-9946.
74. Platt, G. M., Simpson, G. R., Mittnacht, S., and Schulz, T. F. (1999). Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J. Virol. 73, 9789-9795.
75. Polson, A. G., Huang, L., Lukac, D. M., Blethrow, J. D., Morgan, D. O., Burlingame, A. L., and Ganem, D. (2001). Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J. Virol. 75,3175-3184.
76. Prudden, J., Pebernard, S., Raffa, G., Slavin, D. A., Perry, J. J., Tainer, J. A., McGowan, C. H., and Boddy, M. N. (2007). SUMO-targeted ubiquitin ligases in genome stability. EMBO J. 26,4089-4101.
77. Radkov, S. A., Kellam, P., and Boshoff, C. (2000). The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat.Med.6, 1121-1127.
78. Rosas-Acosta, G., Langereis, M. A., Deyrieux, A., and Wilson, V G. (2005). Proteins of the PIAS family enhance the sumoylation of the papillomavirus E1 protein. Virology 331, 190-203.
79. Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., and Poirier, G. G. (2010). PARP inhibition: PARP1 and beyond. Nat. Rev. Cancer 10, 293-301.
80. Schulz, T. F. (2001). KSHV/HHV8-assoicated lymphoproliferations in the AIDS setting. Eur. J. Cancer 37, 1217-1226.
81. Seeler, J. S., Marchio, A., Losson, R., Desterro, J. M., Hay, R. T., Cham-bon, P., and Dejean, A. (2001). Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification. Mol. Cell. Biol. 21, 3314-3324.
82. Song, M. J., Li, X., Brown, H. J., and Sun, R. (2002). Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 76, 5000-5013.
83. Spengler, M. L., Kurapatwinski, K., Black, A. R., and Azizkhan-Clifford, J. (2002). SUMO-1 modification of human cytomegalovirus IE1/IE72. J. Virol. 76, 2990-2996.
84. Stielow, B., Sapetschnig, A., Wink, C., Kruger, I., and Suske, G. (2008). SUMO-modified Sp3 represses transcription by provoking local heterochromatic gene silencing. EMBO Rep. 9, 899-906.
85. Sun, H., Leverson, J. D., and Hunter, T. (2007). Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J. 26, 4102-4112.
86. Sun, R., Lin, S.F.,Gradoville,L., Yuan, Y., Zhu, F., and Miller, G. (1998). Aviral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. U.S.A. 95, 10866-10871.
87. Tassi, E., Biesova, Z., Di Fiore, P. P., Gutkind, J. S., and Wong, W. T. (1999). Human JIK, a novel member of the STE20 kinas family that inhibits JNK and is negatively regulated by epidermal growth factor. J. Biol. Chem. 274, 33287-33295.
88. Tatham, M. H., Geoffroy, M. C., Shen, L., Plechanovova, A., Hattersley, N., Jaffray, E. G., Palvimo, J. J., and Hay, R. T. (2008). RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10, 538-546.
89. Tavalai, N., Papior, P., Rechter, S., Leis, M., and Stamminger, T. (2006). Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J. Virol. 80,8006-8018.
90. Tempera, I., Deng, Z., Atanasiu, C., Chen, C.-J., D'Erme, M., and Lieberman, P. (2010). Regulation of Epstein-Barr virus OriP replication by poly(ADP-ribose) polymerase 1. J. Virol. 84, 4988-4997.
91. Uchimura, Y., Ichimura, T., Uwada, J., Tachibana, T., Sugahara, S., Nakao, M., and Saitoh, H. (2006). Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation. J. Biol. Chem. 281,23180-23190.
92. Uzunova, K., Gottsche, K., Miteva, M., Weisshaar, S. R., Glanemann, C., Schnellhardt, M., Niessen, M., Scheel, H., Hofmann, K., Johnson, E. S., Praefcke, G. J., and Dohmen, R. J. (2007). Ubiquitin-dependent proteolytic control of SUMO conjugates. J. Biol. Chem. 282, 34167-34175.
93. Varjosalo, M., Bjorklund, M., Cheng, F., Synanen, H., Kivioja, T., Kilpinen, S., Sun, Z., Kallioniemi, O., Stunnenberg, H. G., He, W.-W., Ojala, P., and Taipale, J. (2008). Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling. Cell 133, 537-548.
94. Verma, S. C., Borah, S., and Robertson, E. (2004). Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus upregulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J. Virol. 78, 10348-10359.
95. Verma, S. C., Lan, K., and Robertson, E. (2007). Structure and function of latency-associated nuclear antigen. Curr. Top. Microbiol. Immunol. 312, 101-136.
96. Weitzman, M. D., Lilley, C. E., and Chaurushiya, M. S. (2010). Genomes in conflict: maintaining genome integrity during virus infection. Annu. Rev. Microbiol. 64,61-81.
97. West, J. T., and Wood, C. (2003). The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of tran scription activation (RTA) in control of gene expression. Oncogene 22, 5150-5163.
98. Wu, H., Sun, L., Zhang, Y., Chen, Y., Shi, B., Li, R., Wang, Y., Liang, J., Fan, D., Wu, G., Wang, D., Li, S., and Shang, Y (2006). Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation. J. Biol. Chem. 281, 21848-21856.
99. Wu,Y. C., Deyrieux, A. F., and Wilson, V. G. (2007). Papillomaviruses and the host SUMOylation system. Biochem. Soc. Trans. 35,1433-1435.
100. Xie, Y., Kerscher, O., Kroetz, M. B., McConchie, H. F., Sung, P., and Hochstrasser, M. (2007). The yeast Hex3.Slx8 heterodimer is a ubiquitin ligase stimulated by substrate sumoylation. J. Biol. Chem. 282, 34176-34184.
101. Xu, Y., AuCoin, D. P., Huete, A. R., Cei, S. A., Hanson, L. J., and Pari, G. S. (2005). A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J. Virol. 79,3479-3487.
102. Yang, Z., Yan, Z., and Wood, C. (2008). Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication. J. Virol. 82, 3590-3603.
103. Yu, Y., Wang, S. E., and Hayward, G. S. (2005). The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteasome-mediated degradation. Immunity 22, 59-70.
104. Yustein, J. T., Li, D., Robinson, D., and Kung, H. J. (2000). KFC, a Ste20-like kinase with mitogenic potential and capability to activate the SAPK/JNK pathway. Oncogene 19,710-718.
105. Yustein, J. T., Xia, L., Kahlenburg, J. M., Robinson, D., Templeton, D., and Kung, H. J. (2003). Comparative studies of a new subfamily of human Ste-20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38. Oncogene 22, 6129-6141.
106. Zhong, S., Muller, S., Ronchetti, S., Freemont, P. S., Dejean, A., and Pandolfi, P. P. (2000). Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752.
107. Zimnik, S., Gaestel, M., and Niedenthal, R. (2009). Mutually exclusive STAT1 modifications identified by Ubc9/substrate dimerization-dependent SUMOylation. Nucleic Acids Res. 37, e30.